Rchr
J-GLOBAL ID：202001002814916935
Update date: Nov. 05, 2024
Sato Yasuyoshi
サトウ ヤスヨシ | Sato Yasuyoshi
Affiliation and department：
Job title：
Project Assistant Professor
Other affiliations (1)：
Research theme for competitive and other funds (1)：
- 2020 - 2023 肉腫における腫瘍内免疫応答の解析に基づく最適な複合的免疫療法の検討
Papers (56)：
-
Yasuyoshi Sato, Kazuhiko Mori, Shinichiro Atsumi, Kei Sakamoto, Shuichiro Oya, Asami Okamoto, Masayuki Urabe, Yoshiyuki Miwa, Shoh Yajima, Koichi Yagi, et al. Response to chemotherapy could predict the prognosis of esophageal squamous cell carcinoma treated with neoadjuvant docetaxel, cisplatin, and fluorouracil (DCF) followed by surgery: long-term results in a single institute. Esophagus. 2024
-
YASUYOSHI SATO, HIROHARU YAMASHITA, KOICHI YAGI, SACHIYO NOMURA, YASUYUKI SETO. Ramucirumab Beyond Disease Progression After Paclitaxel Plus Ramucirumab in Gastric Cancer: A Phase II Trial. Anticancer Research. 2024. 44. 7. 3125-3131
-
Yasuyoshi Sato, Shunji Takahashi, Takashi Toshiyasu, Hideki Tsuji, Nobuhiro Hanai, Akihiro Homma. Squamous cell carcinoma of the eyelid. Japanese Journal of Clinical Oncology. 2024
-
Naoki Fukuda, Kazuhisa Toda, Hirotaka Suto, Ryosuke Oki, Xiaofei Wang, Tetsuya Urasaki, Yasuyoshi Sato, Kenji Nakano, Makiko Ono, Junichi Tomomatsu, et al. Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib. Endocrine Journal. 2024
-
Yasuyoshi Sato, Hiroharu Yamashita, Yukari Kobayashi, Koji Nagaoka, Tetsuro Hisayoshi, Takuya Kawahara, Akihiro Kuroda, Noriyuki Saito, Ryohei Iwata, Yasuhiro Okumura, et al. Alterations in Intratumoral Immune Response before and during Early-On Nivolumab Treatment for Unresectable Advanced or Recurrent Gastric Cancer. International Journal of Molecular Sciences. 2023. 24. 23
ｍore...
MISC (24)：
-
佐藤 靖祥, 瀬戸 泰之. 【外科医が知っておくべき! 免疫チェックポイント阻害薬】症例紹介 腹水濾過濃縮再静注法(CART)を併用してニボルマブ療法を行いCRが得られた高度腹水を伴う胃癌症例. 臨床外科. 2023. 78. 1. 70-72
-
佐藤 靖祥, 羽山 ブライアン, 大野 真司, 高橋 俊二. COVID-19パンデミック下でのがん専門病院におけるがん患者の受療行動の変化(Changes in Treatment Behavior during the COVID-19 Pandemic among Patients at a Cancer Hospital). 日本癌学会総会記事. 2022. 81回. SP2-5
-
佐藤 靖祥. 新型コロナウイルス感染症によるがん診療及びがん検診の受診状況の変化 COVID-19パンデミック下でのがん専門病院におけるがん患者の受療行動の変化. 日本公衆衛生学会総会抄録集. 2021. 80回. 140-140
-
Yu Fujiwara, Yasuyoshi Sato, Naoki Fukuda, Naomi Hayashi, Xiaofei Wang, Kenji Nakano, Akihiro Ohmoto, Tetsuya Urasaki, Mayu Yunokawa, Makiko Ono, et al. Comparison of triweekly cisplatin regimens in adjuvant chemoradiotherapy for locally advanced head and neck cancer. ANNALS OF ONCOLOGY. 2021. 32. S340-S340
-
Yu Fujiwara, Yasuyoshi Sato, Naoki Fukuda, Naomi Hayashi, Xiaofei Wang, Kenji Nakano, Akihiro Ohmoto, Tetsuya Urasaki, Mayu Yunokawa, Makiko Ono, et al. Comparison of triweekly cisplatin regimens in definitive chemoradiotherapy for locally advanced head and neck cancer: A propensity score matching analysis. JOURNAL OF CLINICAL ONCOLOGY. 2021. 39. 15
ｍore...
Education (2)：
- 2015 - 2019 The University of Tokyo Graduate School of Medicine
- - 2008 Chiba University School of Medicine
Work history (3)：
- 2024/02 - 現在 The University of Tokyo Hospital Department of Clinical Oncology Project Assistant Professor
- 2023/04 - 現在 The Cancer Institute Hospital of Japanese Foundation for Cancer Research Department of Medical Oncology Adjunct Physician
- 2023/04 - 2024/01 The University of Tokyo Hospital Department of Chemotherapy / Cancer Center Project Assistant Professor
Return to Previous Page
